Article Versions Notes

Moreau-Bachelard C, Campion L, Robert M, Kerdraon O, Renaudeau C, Aumont M, Classe J-M, Campone M, Frénel J-S. Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients. Cancers. 2020; 12(12):3725. https://doi.org/10.3390/cancers12123725

Moreau-Bachelard, Camille, Loïc Campion, Marie Robert, Olivier Kerdraon, Céline Renaudeau, Maud Aumont, Jean-Marc Classe, Mario Campone, and Jean-Sébastien Frénel. 2020. "Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients" Cancers 12, no. 12: 3725. https://doi.org/10.3390/cancers12123725

Moreau-Bachelard, C., Campion, L., Robert, M., Kerdraon, O., Renaudeau, C., Aumont, M., Classe, J.-M., Campone, M., & Frénel, J.-S. (2020). Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients. Cancers, 12(12), 3725. https://doi.org/10.3390/cancers12123725